PTX 0.00% 3.9¢ prescient therapeutics limited

PTX chart, page-550

  1. 10,424 Posts.
    lightbulb Created with Sketch. 1155
    Quote - "PTX-100 is much further advanced. It’s already passed its phase one study, in which it was found to be safe and effective within a group of patients with advanced cancers who saw little results from previous therapies. It was well-tolerated and stabilised disease progression for solid tumours, mostly those of the gastrointestinal tract.
    PTX-100 has now entered phase 1B which is led by the world-renowned oncologist, Professor Miles Prince. "
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.